secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enovis CORP (ENOV)
CIK:        0001420800
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001420800-22-000020
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enovis Q3 revenue $384M (+7% organic), adj EPS $0.59 (+34% YoY), guides FY adj EPS $2.20-$2.25
--------------------------------------------------------------------------------

- Reconstructive segment revenue $127M (+15% organic); Prevention & Recovery $257M (+4% organic).
- Reported net loss from continuing ops $(66)M ($(1.22)/diluted share); adjusted EPS grew to $0.59.
- Adjusted EBITDA $57M (14.9% of sales); core margins improved 40 bps despite inflation.
- FY 2022 outlook: organic growth ~6.5%, total sales growth ~10%, adj. EBITDA $235-$240M.
- Launched EMPOWR 3D Knee in Europe and two connected bracing products for Motion iQ platform.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420800/000142080022000020/0001420800-22-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420800/000142080022000020/cfx-20221102.htm
  HTML page:      https://secwatch.observer/filing/0001420800-22-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer